Health Literacy Multi-media Study

May 16, 2017 updated by: Rebecca D. Pentz, PhD, Emory University

Improving Patient Understanding of Key Terms Used to Describe Chemotherapy and Its Side Effects

Cancer patients are presented with a lot of information about their diagnosis and different treatment options, which can be confusing. The purpose of this study is to see if a simple video explanation of six words used to describe cancer treatment improves patient understanding of these words.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Cancer patients are presented with a lot of information about their diagnosis and different treatment options, which can be confusing. The purpose of this study is to see if a simple video explanation of six words used to describe cancer treatment improves patient understanding of these words.

Participants will be interviewed and asked the meaning of six words related to cancer treatment. Following the interview, participants will be shown a video about the meaning of the words. After viewing the video, participants will be re-interviewed to test how effective the video was at explaining the six words.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Georgia
      • Atlanta, Georgia, United States, 30303
        • Grady Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients at Grady Memorial Hospital who is offered a consent to receive chemotherapy

Exclusion Criteria:

  • Profession as a physician or nurse
  • Non English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Education Group
Participants offered a consent for chemotherapy treatment will watch an educational video.
Other: Educational Video
Participants will be asked if they know the meaning of six words related to cancer treatment. Following the interview, participants will watch a video explaining the meaning of the six words. After viewing the video, participants will be re-interviewed about the meaning of the six words.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Correct Responses
Time Frame: Post Intervention (Up to ten minutes)
The number of correct responses to the meaning of the six cancer treatment words will be collected after watching the educational video.
Post Intervention (Up to ten minutes)
Number of Incorrect Responses
Time Frame: Post Intervention (Up to ten minutes)
The number of incorrect responses to the meaning of the six cancer treatment words will be collected after watching the educational video.
Post Intervention (Up to ten minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Emory University

Investigators

  • Principal Investigator: Rebecca Pentz, PhD, Emory University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

December 19, 2016

First Submitted That Met QC Criteria

December 19, 2016

First Posted (Estimate)

December 21, 2016

Study Record Updates

Last Update Posted (Actual)

May 17, 2017

Last Update Submitted That Met QC Criteria

May 16, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IRB00085515

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Educational Video

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe